Evidence map›Paper›PMID 39273257›Full record

ArticleInternational journal of molecular sciences2024

Exploring the Effects and Potential Mechanisms of Hesperidin for the Treatment of CPT-11-Induced Diarrhea: Network Pharmacology, Molecular Docking, and Experimental Validation.

Xinyao Shu, Ruitong Xu, Peiyu Xiong, Junyu Liu, Zubing Zhou, Tao Shen, Xiaobo Zhang

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinyao ShuSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Ruitong XuSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Peiyu XiongSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Junyu LiuSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Zubing ZhouSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0002-0690-4444
Tao ShenSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Xiaobo ZhangSchool of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0002-9916-3832

Funding

Chengdu University of Traditional Chinese Medicine BSH2021016
6 · The paper itself

Abstract

Chemotherapy-induced diarrhea (CID) is a potentially serious side effect that often occurs during anticancer therapy and is caused by the toxic effects of chemotherapeutic drugs on the gastrointestinal tract, resulting in increased frequency of bowel movements and fluid contents. Among these agents, irinotecan (CPT-11) is most commonly associated with CID. Hesperidin (HPD), a flavonoid glycoside found predominantly in citrus fruits, has anti-oxidation properties and anti-inflammation properties that may benefit CID management. Nevertheless, its potential mechanism is still uncertain. In this study, we firstly evaluated the pharmacodynamics of HPD for the treatment of CID in a mouse model, then used network pharmacology and molecular docking methods to excavate the mechanism of HPD in relieving CID, and finally further proved the predicted mechanism through molecular biology experiments. The results demonstrate that HPD significantly alleviated diarrhea, weight loss, colonic pathological damage, oxidative stress, and inflammation in CID mice. In addition, 74 potential targets for HPD intervention in CID were verified by network pharmacology, with the top 10 key targets being AKT1, CASP3, ALB, EGFR, HSP90AA1, MMP9, ESR1, ANXA5, PPARG, and IGF1. The Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that the PI3K-Akt pathway, FoxO pathway, MAPK pathway, TNF pathway, and Ras pathway were most relevant to the HPD potential treatment of CID genes. The molecular docking results showed that HPD had good binding to seven apoptosis-related targets, including AKT1, ANXA5, CASP3, HSP90AA1, IGF1, MMP9, and PPARG. Moreover, we verified apoptosis by TdT-mediated dUTP nick-end labeling (TUNEL) staining and immunohistochemistry, and the hypothesis about the proteins above was further verified by Western blotting in vivo experiments. Overall, this study elucidates the potential and underlying mechanisms of HPD in alleviating CID.

Indexed as

DiarrheaHesperidinIrinotecanMolecular Docking SimulationNetwork PharmacologyAnimalsDisease Models, AnimalMaleMiceOxidative StressHesperidinIrinotecanchemotherapy-induced diarrheaexperimental validationhesperidinmolecular dockingnetwork pharmacology

Identifiers

PMID39273257
PMCPMC11394706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.